{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:17:24Z","timestamp":1789730244240,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jacbts.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T18:14:17Z","timestamp":1572286457000},"page":"736-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Molecularly Detailed NaV1.5 Model Reveals a New Class I Antiarrhythmic Target"],"prefix":"10.1016","volume":"4","author":[{"given":"Jonathan D.","family":"Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wandi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Mangold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woenho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial","volume":"324","author":"Echt","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(96)02149-6","article-title":"Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol","volume":"348","author":"Waldo","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2019.06.002_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002588","article-title":"A\u00a0computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms","volume":"3","author":"Moreno","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jacbts.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1142\/S0218127402005625","article-title":"How antiarrhythmic drugs increase the rate of sudden cardiac death","volume":"12","author":"Starmer","year":"2002","journal-title":"Int J Bifurcation Chaos"},{"key":"10.1016\/j.jacbts.2019.06.002_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature10238","article-title":"The crystal structure of a voltage-gated sodium channel","volume":"475","author":"Payandeh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jacbts.2019.06.002_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1006\/jmcc.2000.1346","article-title":"The cardiac sodium channel: gating function and molecular pharmacology","volume":"33","author":"Balser","year":"2001","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1085\/jgp.20028651","article-title":"Molecular action of lidocaine on the voltage sensors of sodium channels","volume":"121","author":"Sheets","year":"2003","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/CIRCRESAHA.118.314050","article-title":"Predicting patient response to the antiarrhythmic mexiletine based on genetic variation","volume":"124","author":"Zhu","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacbts.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3495(98)77490-9","article-title":"Spiral waves in two-dimensional models of ventricular muscle: formation of a stationary core","volume":"75","author":"Beaumont","year":"1998","journal-title":"Biophys J"},{"key":"10.1016\/j.jacbts.2019.06.002_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bpj.2017.11.024","article-title":"How to connect cardiac excitation to the atomic interactions of ion channels","volume":"114","author":"Silva","year":"2018","journal-title":"Biophys J"},{"key":"10.1016\/j.jacbts.2019.06.002_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/19336950.2017.1369637","article-title":"Mechanisms and models of cardiac sodium channel inactivation","volume":"11","author":"Mangold","year":"2017","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.jacbts.2019.06.002_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150761","article-title":"Parameterization for in-silico modeling of ion channel interactions with drugs","volume":"11","author":"Moreno","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2019.06.002_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.mex.2016.11.001","article-title":"A\u00a0computationally efficient algorithm for fitting ion channel parameters","volume":"3","author":"Teed","year":"2016","journal-title":"MethodsX"},{"key":"10.1016\/j.jacbts.2019.06.002_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2009.09.019","article-title":"A\u00a0novel computational model of the human ventricular action potential and Ca transient","volume":"48","author":"Grandi","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2019.06.002_bib16","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/CIRCEP.115.003155","article-title":"Direct measurement of cardiac Na+ channel conformations reveals molecular pathologies of inherited mutations","volume":"8","author":"Varga","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pbiomolbio.2015.12.003","article-title":"Molecular motions that shape the cardiac action potential: insights from voltage clamp fluorometry","volume":"120","author":"Zhu","year":"2016","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1085\/jgp.201611678","article-title":"Regulation of Na+ channel inactivation by the DIII and DIV voltage-sensing domains","volume":"149","author":"Hsu","year":"2017","journal-title":"J\u00a0Gen Physiol"},{"issue":"Pt 1","key":"10.1016\/j.jacbts.2019.06.002_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1113\/jphysiol.2007.134262","article-title":"Outward stabilization of the S4 segments in domains III and IV enhances lidocaine block of sodium channels","volume":"582","author":"Sheets","year":"2007","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators","volume":"321","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacbts.2019.06.002_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004400","article-title":"Revealing the concealed nature of long-QT type 3 syndrome","volume":"10","author":"Greer-Short","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib22","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ddmod.2010.03.001","article-title":"Using computational modeling to predict arrhythmogenesis and antiarrhythmic therapy","volume":"6","author":"Moreno","year":"2009","journal-title":"Drug Discov Today Dis Models"},{"key":"10.1016\/j.jacbts.2019.06.002_bib24","doi-asserted-by":"crossref","first-page":"H766","DOI":"10.1152\/ajpheart.01081.2011","article-title":"Computational approaches to understand cardiac electrophysiology and arrhythmias","volume":"303","author":"Roberts","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1085\/jgp.201010438","article-title":"Molecular mechanism of allosteric modification of voltage-dependent sodium channels by local anesthetics","volume":"136","author":"Arcisio-Miranda","year":"2010","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib26","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1085\/jgp.69.4.497","article-title":"Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction","volume":"69","author":"Hille","year":"1977","journal-title":"J\u00a0Gen Physiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.84.3.1364","article-title":"Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments","volume":"84","author":"Starmer","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2019.06.002_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.pa.24.040184.002131","article-title":"Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs","volume":"24","author":"Hondeghem","year":"1984","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib29","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1529\/biophysj.103.038679","article-title":"How to impose microscopic reversibility in complex reaction mechanisms","volume":"86","author":"Colquhoun","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.jacbts.2019.06.002_bib30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrcardio.2009.44","article-title":"Sodium channel mutations and arrhythmias","volume":"6","author":"Ruan","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacbts.2019.06.002_bib31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00000542-199204000-00005","article-title":"The use of oral mexiletine for the treatment of pain after peripheral nerve injury","volume":"76","author":"Chabal","year":"1992","journal-title":"Anesthesiology"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X19301846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X19301846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:21:52Z","timestamp":1762820512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X19301846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2452302X19301846"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2019.06.002","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Molecularly Detailed NaV1.5 Model Reveals a New Class I Antiarrhythmic Target","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}